1. Cerebrolysin improves clinical outcome in moderate to moderately severe vascular dementia: results from a randomized, double-blind, placebo-controlled, multicenter trial;Guekht;European Journal of Neurology,2009
2. Cerebrolysin in vascular dementia: improvement of clinical outcome in a randomized, double-blind, placebo-controlled multicenter trial;Guekht;Journal of Stroke and Cerebrovascular Diseases,2011
3. NCT00947531 A clinical trial to evaluate the safety and efficacy of 20 ml Cerebrolysin in patients with Vascular Dementia (VascDem) clinicaltrials.gov/ct2/show/study/NCT00947531
4. The efficacy of Cerebrolysin in multi-infarct dementia;Liang;Heilongjiang Medicine and Pharmacy,2001
5. A pilot study to evaluate the effects of Cerebrolysin on cognition and qEEG in vascular dementia: cognitive improvement correlates with qEEG acceleration;Muresanu;Journal of the Neurological Sciences,2008